![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pfizer | LSE:PFZ | London | Ordinary Share | COM STK USD0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.78 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPFZ
RNS Number : 4661G
Goldman Sachs & Co.
20 November 2015
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION Name of exempt principal (GS) GOLDMAN, SACHS trader & CO. ======================== =================== Company dealt in PFIZER INC ======================== =================== Class of relevant USD ordinary security to which the dealings being disclosed relate (Note 1) ======================== =================== Date of dealing 19 November 2015 ======================== =================== 2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
Long Short =========================== ================= =================== Number (%) Number (%) =========================== ======= ======== =========== ====== 944,294 (1) Relevant securities 0 (0.00) (0.01) =========================== ================= =================== (2) Derivatives (other than options) 0 (0.00) 0 (0.00) =========================== ================= =================== (3) Options and agreements to purchase/sell 0 (0.00) 0 (0.00) =========================== ================= =================== 944,294 Total 0 (0.00) (0.01) =========================== ================= ===================
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant Long Short security: ========================== =================== ===================== Number (%) Number (%) ========================== ========= ====== =========== ====== (1) Relevant securities ========================== =================== ===================== (2) Derivatives (other than options) ========================== =================== ===================== (3) Options and agreements to purchase/sell ========================== =================== ===================== Total ========================== =================== =====================
Ap28
3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of relevant Price per securities unit (Note 4) ================= ========================= ================ Purchase (Loan 56,767 N/A Partial Return) ================= ========================= ================ Purchase (Loan 217,800 N/A Full Return) ================= ========================= ================ Sale (Loan 908,499 N/A New) ================= ========================= ================ Purchase (Loan 878,096 N/A Full Return) ================= ========================= ================ Sale (Loan 30,403 N/A New) ================= ========================= ================ Purchase (Loan 30,403 N/A Full Return) ================= ========================= ================ Purchase (Loan 463 N/A Partial Return) ================= ========================= ================ Purchase (Loan 657 N/A Partial Return) ================= ========================= ================ Purchase (Loan 337 N/A Partial Return) ================= ========================= ================ Purchase (Loan 215 N/A Partial Return) ================= ========================= ================ (b) Derivatives transactions (other than options transactions) Product Nature of Number of relevant Price name, transaction securities per unit e.g. CFD (Note 5) (Note 6) (Note 4) ========== ============= =================== ========== (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product Writing, Number Exercise Type, Expiry Option name, selling, of securities price e.g. date money e.g. purchasing, to which American, paid/received call varying the option European per unit option etc. relates etc. (Note (Note 4) 7) ======== ============= =============== ========= =========== ====== =============== (ii) Exercising Product name, Number of securities Exercise price e.g. call per unit (Note option 4) ============== =========================== ==================== (d) Other dealings (including transactions in respect of new securities) (Note 3) Nature of Details Price per transaction unit (Note 7) (if applicable) (Note 4) ============= ============== =====================
Ap29
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities
under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES/NO Date of disclosure 20 November 2015 ======================== ==================== Contact name Aadithya Rao and Yiannis Bardis ======================== ==================== +44(20) 7051 9046 Telephone number / +44(20) 7774 7107 ======================== ==================== Name of offeree/offeror Pfizer Inc with which connected ======================== ==================== Nature of connection Advisor to Offeror (Note 9) ======================== ====================
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEEAFFEASLSFFF
(END) Dow Jones Newswires
November 20, 2015 06:57 ET (11:57 GMT)
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions